Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Acute stress induces changes in epigenome-wide DNA methylation
    Published on 2025-12-11
    6 months ago
  • Aberrant effective connectivity during working memory performance in schizotypal personality disorder and schizophrenia: A spectrum approach
    Published on 2025-12-10
    6 months ago
  • Corticosterone accelerates behavioral inflexibility via plasticity-related gene expression in the dorsal striatum
    Published on 2025-12-08
    6 months ago
  • ENX-104: a selective and potent D2/D3 receptor antagonist enhances dopamine neurotransmission and reward responsiveness in translational rodent models
    Published on 2025-12-06
    6 months ago
  • Getting into the weed—the genetics of cannabis use in modern America
    Published on 2025-12-01
    6 months ago
  • The hippocampus as a central hub in ketamine’s antidepressant action: from molecules to circuit rewiring
    Published on 2025-11-25
    6 months ago
  • Orbitofrontal BDNF puts the brakes on alcohol intake and relapse
    Published on 2025-11-24
    6 months ago
« Previous 1 … 22 23 24 25 26 … 143 Next »
Journal of Psychopharmacology
  • OAV and 5D-ASC for Brazilian Portuguese: A validation and adaptation study
    Published on 2025-06-28
    11 months ago
  • Acute effects of 150 mg caffeine on subjective, physiological, and behavioral components of anxiety in panic disorder and healthy controls – A randomized placebo-controlled crossover trial
    Published on 2025-06-27
    11 months ago
  • Fluoroquinolones and risk of nightmares: A literature review and disproportionality analysis using individual case safety reports from Food and Drug Administration Adverse Event Reporting System database
    Published on 2025-06-27
    11 months ago
  • A randomized, double-blind, placebo-controlled, Phase 1 study to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of an immediate-release oral ketamine capsule in healthy volunteers
    Published on 2025-06-20
    11 months ago
  • GABA and Glx levels in cortico-subcortical networks predict catecholaminergic effects on response inhibition
    Published on 2025-06-20
    11 months ago
  • Adolescent substance use trajectories are associated with nucleus accumbens functional connectivity
    Published on 2025-06-20
    11 months ago
  • Development and validation of the Comprehensive Cannabis Motives Questionnaire (CCMQ)
    Published on 2025-06-20
    11 months ago
« Previous 1 … 22 23 24 25 26 … 146 Next »
European Neuropsychopharmacology
  • Editorial Board
    Published on 2025-06-12
    12 months ago
  • Pharmacological profiling of major depressive disorder-related multimorbidity clusters
    Published on 2025-06-08
    12 months ago
  • Age at onset and trajectory to mania
    Published on 2025-05-27
    1 year ago
  • Making symptom measurement feasible: The clinical case for PANSS-6
    Published on 2025-05-23
    1 year ago
  • Comparative mortality risk of antipsychotics in 41,695 patients with schizophrenia: an 11-year population-based cohort study in Hong Kong
    Published on 2025-05-23
    1 year ago
  • Pharmacological treatments for atypical depression: A systematic review and network meta-analysis of randomized controlled trials
    Published on 2025-05-23
    1 year ago
  • Antidepressant use during pregnancy and risk of obstetrics and neonatal outcomes: A propensity score-weighted population-based cohort study in 2003–2018
    Published on 2025-05-23
    1 year ago
« Previous 1 … 22 23 24 25 26 … 166 Next »

   Pharma Pub